A detailed history of Delta Investment Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Delta Investment Management, LLC holds 6,210 shares of ABT stock, worth $712,659. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,210
Previous 6,645 6.55%
Holding current value
$712,659
Previous $690,000 2.61%
% of portfolio
0.16%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $43,530 - $51,386
-435 Reduced 6.55%
6,210 $708,000
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $52,480 - $58,581
-521 Reduced 7.27%
6,645 $690,000
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $37,893 - $41,852
346 Added 5.07%
7,166 $814,000
Q4 2023

Feb 02, 2024

SELL
$90.19 - $110.4 $77,653 - $95,054
-861 Reduced 11.21%
6,820 $750,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $32,575 - $39,085
341 Added 4.65%
7,681 $743,000
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $201 - $224
-2 Reduced 0.03%
7,340 $800,000
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $11,235 - $13,225
116 Added 1.61%
7,342 $743,000
Q4 2022

Jan 19, 2023

BUY
$95.06 - $111.52 $18,536 - $21,746
195 Added 2.77%
7,226 $0
Q3 2022

Oct 21, 2022

BUY
$96.76 - $112.03 $206,679 - $239,296
2,136 Added 43.64%
7,031 $680,000
Q2 2022

Jul 20, 2022

BUY
$102.07 - $123.37 $7,042 - $8,512
69 Added 1.43%
4,895 $532,000
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $115 - $141
1 Added 0.02%
4,826 $679,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $5,249 - $5,807
45 Added 0.94%
4,825 $570,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $121,552 - $143,084
-1,149 Reduced 19.38%
4,780 $554,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $243,257 - $286,594
-2,235 Reduced 27.38%
5,929 $711,000
Q4 2020

Feb 04, 2021

BUY
$105.0 - $114.42 $165,060 - $179,868
1,572 Added 23.85%
8,164 $893,000
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $83,300 - $101,162
-909 Reduced 12.12%
6,592 $717,000
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $9,035 - $11,564
118 Added 1.6%
7,501 $685,000
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $139,837 - $204,480
2,226 Added 43.16%
7,383 $582,000
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $404,876 - $450,721
5,157 New
5,157 $447,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Delta Investment Management, LLC Portfolio

Follow Delta Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Investment Management, LLC with notifications on news.